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Introduction
Methods
Hypothesis
Results
Discussion
The hypothesis was supported - propranolol hydrochloride decreased heart rate, and 
atropine increased heart rate in the D. mel larvae. This was confirmed by a t-test in which 
the means for both experimental groups were shown to be significant when compared to 
the control group.
This research suggests that D. mel has potential to be an accurate model of human 
cardiac disease. Further, since D. mel can respond similarly to commonly prescribed heart 
medication, it could be used in preliminary pharmaceutical testing for new medication. 
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Every 40 seconds one American dies of cardiac disease.1 Current models of human cardiac 
disease may be similar in anatomy and physiology, but are often expensive and tedious to 
work with. The current need is for a model organism that is more efficient to work with in 
lab while still an accurate model of human cardiac disease. 
Drosophila melanogaster (D. mel) is a more efficient organism to work with in lab due to its 
short life span, low cost, and the feasibility of culturing.2,3,4 Anatomically the D. mel heart 
differs from the human heart in that it has only one chamber, one layer of cardiomyocytes, 
and lacks coronary arteries. It is similar, however, in protein and genetic makeup allowing 
the D. mel heart to develop structural defects, arrhythmias, and cardiomyopathies similarly 
to the human heart.5,6
Atropine increases heart rate by  preventing acetylcholine from affecting sinoatrial and 
atrioventricular nodes by blocking muscarinic acetylcholine receptors (mAchRs). In D. mel, 
one of the two types of mAchRs are similar to humans. 7,8
Propranolol hydrochloride is a β-blocker that reduces heart rate by blocking beta1-
adrenergic receptors (βARs). D. mel possesses a family of G-protein receptors that are 
structurally and functionally related to βARs. 9,10,11
I hypothesized that atropine and propranolol hydrochloride in the growth 
media of third instar larvae would cause an increase and decrease respectively 
in the heart rates of D. mel. 
0
50
100
150
200
250
300
350
400
450
500
Control Propranolol hydrochloride Atropine
A
ve
ra
ge
 H
ea
rt
 R
at
e 
(b
ea
ts
/m
in
u
te
) 
[S
ta
n
d
ar
d
 D
ev
ia
ti
o
n
]
Figure 1 Average Heart Rate of Control, 
Propranolol hydrochloride and Atropine 
Groups 
Average Heart 
Rate in 
Beats/min
Standard 
Deviation
Control 387.653 14.623
Propranolol 
hydrochloride
274.533 19.084
Atropine 406.373 22.477
T-Test Significance
Control and 
Propranolol 
hydrochloride
3.368E-55
Control and 
Atropine
3.265E-06
Day 1:
▪ Adult flies moved to fresh vials
Days 2-5:
▪ Adult flies mated
▪ Larvae hatched and grew
Day 6: 
▪ 2st instar larvae moved to fresh media
▪ Control – no medication 
▪ Experimental groups – 1mM atropine or 1mM propranolol 
hydrochloride
Day 7:
▪ 3rd instar larvae heart rates recorded
Recording Heart Rate: 
▪ Three heart rates were recorded in fifteen second intervals for each 
larva. 
▪ This was done by using a tap counter and a fifteen second timer with 
a ten second interval of rest in between. 
▪ The three heart rates for each of the fifty larvae in each group were 
averaged. 
Table 1 Average Heart Rate and 
Standard Deviation of Control, 
Propranolol hydrochloride, and 
Atropine Groups 
Table 2 T-Test Results and Significance
